Impact of Serum High Mobility Group Box 1 and Soluble Receptor for Advanced Glycation End-Products on Subclinical Atherosclerosis in Patients with Granulomatosis with Polyangiitis

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions